908 Devices Announces Potential IPO Pricing
908 Devices intends to price more than 6 million shares to result in an initial public offering valued up to about $122 million.
All Work
Chris Lange
How CureVac Is Advancing in the Fight Against COVID-19
CureVac advanced in the fight against COVID-19 by beginning enrollment in its midstage vaccine candidate study. As a result, investors cheered on this news and sent shares higher.
Nio Cashes in Big With Another Huge Secondary Offering
Nio shares dipped on Friday after the electric vehicle manufacturer would be conducting a secondary offering.
Is Lululemon’s Valuation Holding It Back After Earnings Beat?
Although the quarterly numbers were solid, Lululemon stock ultimately fell. This goes to show that even a solid earnings beat can still be trumped by runaway valuations that are hard to justify.
Amazing Comparable Sales Aren’t Enough to Move the Needle for Costco
Costco reported better than expected quarterly results after the closing bell on Thursday.
Does Oracle Deserve More Credit for Q2 Results?
Oracle reported its most recent quarterly results after the closing bell on Thursday.
Broadcom Fails to Impress Despite Solid Earnings Beat
Broadcom reported its most recent quarterly results after the markets closed on Thursday.
Airbnb’s Incredible IPO
Airbnb entered the market with a bang in its IPO on Thursday. The stock came in at $146 above its pricing at $68 per share. This was also well above the expected price range…
Is Major Semiconductor Short Interest Signalling Further Market Highs?
The November 30 short interest data have been compared with the previous report, and short interest in most of these selected semiconductor stocks increased.
Which Big Biotechs Short Sellers Favor Now
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Is the DoorDash IPO Overvalued?
DoorDash entered the market with a bang on Wednesday in its initial public offering.
Is Cardtronics Getting Enough From This Acquisition Offer?
Cardtronics was one of the biggest movers on Wednesday after the company confirmed that it received an offer to be bought out.
The Hits Keep Coming With Curis’s Secondary Offering
Curis shares are on the run again. This time it’s due to a secondary offering.
GameStop Is Cautiously Optimistic Despite Earnings Flop
GameStop reported its most recent quarterly results after the markets closed on Tuesday.
QuantumScape’s Lithium Batteries Could Be a Gamechanger
QuantumScape stock jumped on Tuesday after the firm released performance data for its tech regarding its next-generation solid-state lithium-metal batteries for use in electric vehicles.
This Curis Cancer Study Is a Big Hit
Curis has announced preliminary data from its ongoing early-stage study in patients with acute myeloid leukemia or high-risk myelodysplastic syndromes.
The Earnings Surprise at Stitch Fix May Not Have Been the Biggest News
Stitch Fix reported a big earnings surprise after the close bell on Monday, and a huge addition to management.
Is Kodak Now a Stock to Buy After Being Cleared of ‘Wrongdoing’?
Kodak has been a favorite for retail traders lately, with its massive volume and even greater swings. This stock received a resounding vote of confidence from traders on Monday in regards to its “suspect”…
Is the FDA’s CRL on scPharma Justified?
After scPhamaceuticals announced that it had received a Complete Response Letter from the FDA, its shares were absolutely crushed on Monday.
GameStop, Campbell Soup, Stitch Fix, Broadcom, Costco, and More Major Earnings Coming This Week
Here, 24/7 Wall St. has put together a preview of a few of the most anticipated quarterly reports expected this week.